The efficacy, safety, and cost-effectives of combined administration of Intravenous and Local Tranexamic Acid in the management of Patients Undergoing Primary Total Hip Arthroplasty: A prospective, blinded and randomized clinical study
- 4 November 2021
- journal article
- research article
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 55 (5), 422-427
- https://doi.org/10.5152/j.aott.2021.20397
Abstract
Objective: The aim of this study was to compare the efficacy, safety, and cost-effectiveness of combined administration of intravenous and local tranexamic acid with those of either intravenous or local administrations in patients undergoing primary total hip arthroplasty (THA). Methods: This prospective, blinded, and randomized clinical study was performed on patients undergoing unilateral primary THA from September 2018 to December 2019. A total of 90 patients were included and prospectively allocated to one of three groups: the combined group (n = 30, 14 male, 16 female; mean age = 54.9 +/- 12 years), intravenous (IV) group (n = 30, 13 male, 17 female; mean age = 54.9 +/- 12.3 years), and local group (n = 30, 13 male, 17 female; 50.3 +/- 12.3). Tranexamic acid was used systemically by IV application (15mg/kg) in IV group, locally in the surgical field (2g) in local group as well as combined systemic and local together in combined group. The amount of blood loss, number of erythrocyte suspension transfusion, and changes in hemoglobin and hematocrit levels were documented accordingly. The estimated mean tranexamic acid and erythrocyte suspensions cost, extra nurse care, monitoring and laboratory costs associated with blood transfusion, and total hospital costs were compared among groups. Results: No differences existed in hemoglobin and hematocrit levels after surgery among the groups. The combined group required fewer blood transfusion compared to the local and IV groups, and the total amount of ES was statistically significantly lower (P = 0.039) in the combined group. Although the medication cost was higher in the combined group than in the other groups (P< 0.001), combined group was more cost-effective (P < 0.001) when the total costs related to blood loss were evaluated. No occurrence of deep vein thrombosis or pulmonary embolism was found in the study. Conclusion: Combined administration of IV and local tranexamic acid seems to be more effective in reducing the requirement and amount of blood transfusion without increasing the risk of thromboembolic complications in primary THA compared to IV or local administrations. Despite increasing the prophylaxis costs, combined administration of TXA can result in lower total hospitalization costs by decreasing blood loss and consequent treatment costs in primary THA.Keywords
This publication has 21 references indexed in Scilit:
- Comparison of Topical and Intravenous Tranexamic Acid on Blood Loss and Transfusion Rates in Total Hip ArthroplastyThe Journal of Arthroplasty, 2014
- Topical Tranexamic Acid Reduces Transfusion Rates in Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2014
- Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2014
- Economic Impact of Tranexamic Acid in Healthy Patients Undergoing Primary Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2013
- Transfusion Rates Are Increasing Following Total Hip Arthroplasty: Risk Factors and OutcomesThe Journal of Arthroplasty, 2013
- Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates in Total Hip and Total Knee ArthroplastyThe Journal of Arthroplasty, 2013
- The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplastyKnee Surgery, Sports Traumatology, Arthroscopy, 2012
- The cost of blood transfusion in Western Europe as estimated from six studiesTransfusion, 2012
- Tranexamic Acid Reduces Allogenic Transfusion in Revision Hip ArthroplastyClinical Orthopaedics and Related Research, 2011
- Tranexamic acid reduces blood loss after cementless total hip arthroplasty?prospective randomized study in 40 casesInternational Orthopaedics, 2004